Abstract
Prenatal exposure to bisphenol A (BPA) influences the development of sex differences neurologically and behaviorally across many species of vertebrates. These effects are a consequence of BPA’s estrogenic activity and its ability to act as an endocrine disrupter even, at very low doses. When exposure to BPA occurs during critical periods of development, it can interfere with the normal activity of sex steroids, impacting the fate of neurons, neural connectivity and the development of brain regions sensitive to steroid activity. Among the most sensitive behavioral targets of BPA action are behaviors that are characterized by a sexual dimorphism, especially emotion and anxiety related behaviors, such as the amount of time spent investigating a novel environment, locomotive activity and arousal. Moreover, in some species of rodents, BPA exposure affected males’ sexual behaviors. Interestingly, these behaviors are at least in part modulated by the catecholaminergic system, which has been reported to be a target of BPA action. In the present study we investigated the influence of prenatal exposure of mice to a very low single dose of BPA on emotional and sexual behaviors and on the density and binding characteristics of alpha2 adrenergic receptors. Alpha2 adrenergic receptors are widespread in the central nervous system and they can act as autoreceptors, inhibiting the release of noradrenaline and other neurotransmitters from presynaptic terminals. BPA exposure disrupted sex differences in behavioral responses to a novel environment, but did not affect male mice sexual behavior. Importantly, BPA exposure caused a change in the binding affinity of alpha2 adrenergic receptors in the locus coeruleus and medial preoptic area (mPOA) and it eliminated the sexual dimorphism in the density of the receptors in the mPOA.
Keywords: bipshenol A, estrogen, alpha2 adrenergic receptors, sex differences, catecholamines, ethology
1. Introduction
Bisphenol A (BPA) is an environmentally ubiquitous monomer used in the synthesis of polycarbonate plastics and epoxy resins that are employed in the manufacturing of food and beverage containers and dental sealants [1]. BPA is found in measurable amounts in human tissues, organs and biological fluids, such as blood, placenta and breast milk [2,3,4] levels that are not due to assay or laboratory contamination, but from every-day environmental exposure [5], implying that human fetuses and infants are at risk of exposure. Owing to its ability to bind intracellular and membrane-associated estrogen receptors, BPA acts similarly to endogenous estrogen leading to the activation of genomic and nongenomic mechanisms [6] that, during period of early development and plasticity, have long term effects on several neuroendocrine systems [7,8] and behaviors [9]. In this regard, abundant experimental data show that BPA can interfere with the development of the central nervous system at doses below its US reference dose of 50 ug/kg/day and within the estimated daily intake for adults and children [10].
Among the most sensitive endpoints of an early exposure to BPA are those systems and traits that will develop to become sexually dimorphic in the adult. Sexual dimorphism is the result of a complex interaction between the sex complement (the differences within males’ and females’ cells in the expression of genes associated with sex chromosomes) and the organizational role that sex steroids play during critical periods of development [11]. Perinatal exposure to sex steroids exerts a potent, long term influence on the developing nervous system. These effects result in permanent sex differences involving the number and size of neurons, synaptic formation, dendritic length and distribution patterns of serotoninergic, dopaminergic and noradrenergic systems [12,13]. Through its aromatization to estradiol, in rodents testosterone causes masculinization and defeminization of males’ brain structures and of behaviors under their control [12].
Amid the first areas of the CNS that were found to be sexually dimorphic are regions regulating reproductive behaviors, such as the medial preoptic area (mPOA) and the anteroventral periventricular nucleus (AVPV) of the hypothalamus [14]. However, differences in the size of brain nuclei, number of cells and connectivity have been found in other regions of the brain not directly involved with reproductive behaviors, such as the hippocampus [15], the locus coeruleus (LC) [16], the amygdala and other limbic regions [14,17]. The LC is a noradrenergic nucleus of the brainstem that is involved in arousal, vigilance, attention, cognition and the stress response [18,19,20]. In the rat, the perinatal surge of testosterone induces a clear sex difference in the volume of the adult’s LC, with females’ LC that is larger [16,21]. In mice, a similar but transient sexual difference in the number of tyrosine hydroxylase (TH; the rate limiting enzyme for dopamine and noradrenaline) neurons is observed and possibly mediated by estrogen-β receptors [22]. Perinatal exposure to low doses of BPA reduced the sex differences in LC volume in rats [23,24] and mice [25]: in these studies BPA also eliminated sex differences in exploratory behaviors and locomotor activity in the open field (OF), consistently with previous studies from our laboratory [26,27]. Such a behavioral response to a novel environment reflects increased arousal and is assumed to be, at least in part, modulated by the noradrenergic system.
The medial preoptic area (mPOA) of the hypothalamus is a sexually dimorphic area that regulates sex behaviors in males [28,29] and maternal behavior [30]. This area is composed of several sexually dimorphic subregions, such as the sexually dimorphic nucleus (SDN) of the POA, which is larger in males [31] and the AVPV, larger in females [32]. The mPOA is rich in estrogen receptors [14], in adrenergic receptors and innervation originating from the LC [33] and in neurons expressing TH [14]. In this regard, a sexually dimorphic population of neurons expressing TH which is dependent on ERalpha receptors has been reported [34]. Catecholaminergic innervation of the mPOA is necessary for the luteinizing hormone (LH) surge that precedes ovulation [35], and for the expression of lordosis, in female rats [36], and for males’ sexual behavior, possibly through a mechanism that involves the binding of dopamine to alpha2 adrenergic receptors [37,38]. The sexual dimorphism in these hypothalamic areas was reduced by early exposure to low doses of BPA [39,40]. Likewise, a similar exposure paradigm to BPA affected sex specific behaviors such as maternal care in mice [41] and behaviors related to reproduction in rats [42,43].
Based on our previously reported sex-dependent effects of prenatal exposure to BPA on behavioral responses mediated by the catecholaminergic system of the house mouse [44], in the present study we investigated whether the exposure to the same low dose of BPA (10 µg/Kg BW) had long term, sex dependent disruptive effects on the noradrenergic system. This dose is below the US reference dose of 50 ug/kg/day, but above the EU tolerable daily intake of 4 ug/kg/day (http://www.efsa.europa.eu/en/topics/topic/bisphenol). First, we investigated the effects of this exposure regime on sex differences in reproductive and emotional behaviors that are, at least in part, modulated by the catecholaminergic system. Then, we explored the possible functional link between behavior and neurobiology by studying the density and affinity of alpha2-adrenergic receptor in the LC and mPOA, two sexually dimorphic areas associated with anxiety and reproductive behaviors. Alpha2-adrenergic receptors are transmembrane proteins that belong to the monoaminergic receptor family involved in behavior, cognitive function, mood and stress [45,46,47]. They are widespread in central nervous system [45,47,48], and when present presynaptically, they act as autoreceptors, and thereby inhibit the release of neurotransmitters [46]. Thus, the aim of the present study was to investigate the effects of an established low dose of BPA on sex differences in anxiety-like behaviors and the central catecholaminergic system in the adult mouse.
2. Results
2.1. Preliminary Analysis
Table 1 shows the descriptive statistics of the study. Preplanned comparisons were carried out to evaluate whether males and females within the same treatment group were different from each other. Cohen’s d shows the standardized difference of the effect, and thus indicates the overall effect size. Based on Cohen’s rules for defining the effect size, a d = 0.2 is regarded as small effect, d = 0.5 a medium effect and d =.8 a large effect [49].
Table 1.
OIL | BPA | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
Females | Males | Females | Males | |||||||
Outcome | M | SD | M | SD | d | M | SD | M | Sd | d |
FOF | ||||||||||
Exp | 143.10 | 105.78 | 100.05 | 74.48 | 0.46 [−0.27; 1.21] | 140.81 | 96.81 | 54.73 | 70.98 | 1.01 [0.22; 1.79] * |
RA | 35.5 | 27.63 | 33.9 | 31.18 | 0.46 [−0.27; 1.21] | 27.92 | 31.03 | 19.93 | 17.14 | 0.43 [−0.31; 1.17] |
Rear | 0.45 | 1.19 | 0.18 | 0.41 | 0.29 [−0.43; 1.02] | 0.12 | 0.48 | 1.35 | 1.96 | 0.85 [0.08; 1.61] |
EPM | ||||||||||
%CA | 56.37 | 12.52 | 71.96 | 13.03 | 1.21 [0.41; 2.02]* | 66.10 | 16.43 | 68.00 | 13.55 | 0.12 [−0.84; 0.60] |
%CE | 31.45 | 11.23 | 18.84 | 7.14 | 1.33 [0.53; 2.14]* | 21.77 | 10.44 | 19.65 | 10.78 | 0.20 [−0.52; 0.92] |
HD | 20.35 | 6.23 | 12.85 | 5.03 | 1.32 [0.52; 2.12]* | 14.42 | 4.92 | 13.78 | 5.95 | 0.11 [−0.60; 0.84] |
RA | 21.87 | 6.66 | 20.42 | 4.53 | 0.25 [−0.55; 1.05] | 18.5 | 5.74 | 17.28 | 5.92 | 0.20 [−0.51; 0.93] |
POA | ||||||||||
Density | 177.81 | 15.92 | 161.97 | 13.25 | 1.08 [0.04; 2.11] | 182.40 | 19.42 | 174.87 | 17.02 | 0.40 [−0.53; 1.34] |
Kd | 1.65 | 0.40 | 1.29 | 0.45 | 0.29 [−1.23; 0.65] | 1.70 | 0.46 | 1.59 | 0.37 | 0.26 [−0.73; 1.26] |
LC | ||||||||||
Density | 195.72 | 7.99 | 190.06 | 9.99 | 0.62 [−0.37; 1.62] | 195.00 | 14.61 | 192.88 | 9.43 | 0.17 [−0.81; 1.15] |
Kd | 0.76 | 0.9 | 0.74 | 0.11 | 0.10 [−0.87; 1.08] | 0.92 | 0.15 | 0.88 | 0.15 | 0.23 [−0.47; 1.21] |
Note. FOF = free exploratory open field; Exp = total exploration time (s); RA = total risk assessment (s); Rear = total rearing (s); EPM = elevated Plus Maze; %CA = % time in closed arms; %CE = % time in center; HS = total number of head dips; RA = total time in risk assessment; POA = preoptic area; LC = locus coeruleus; d = Cohen’s d, presented with 95% confidence interval; * p < 0.025 (preplanned comparisons with Bonferroni’s adjustment).
2.2. Effects of Prenatal Exposure to BPA on Behaviors during the Free-Exploratory Open Field (FOF)
In relation to the total time spent exploring the arena, independently of treatment, females explored more than males, F(1,52) = 7.49, p < 0.01, ŋp2 = 0.12 (Figure 1), but no main effect nor a sex dependent effect of BPA was found. However, our preliminary analysis with planned comparisons and effect size showed a large difference between males and females of the BPA group in relation to total exploration (d = 1.01), with the true effect size ranging from small to large (Table 1). No effects were found in relation to total risk assessment, while a significant interaction between BPA exposure and sex was found for total rearing, F(1,52) = 5.42, p < 0.05, ŋp2 = 0.09. BPA-exposed males performed more vertical exploration compared to BPA females (p = 0.04) (Figure 1).
2.3. Effects of Prenatal Exposure to BPA on Behaviors in the Elevated Plus Maze (EPM)
Independently of BPA exposure, females spent less time in the closed arms of the EPM compared to males, F(1,52) = 5,48, p =.02, ŋp2 = 0.09, while no main effect nor a sex dependent effect of BPA was found. Our exploratory analysis showed that males spent significantly more time in the closed arms compared to females (d = 1.21), with the true effect size ranging from medium to large, but this difference was not found in the BPA group (Figure 2). A similar result was found for the proportion of time spent in the center. Independently of BPA exposure, females spent more time in the center of the maze compared to males, F(1,52) = 7.54, p <.001, ŋp2 = 0.12. This main effect was qualified by a statistically significant interaction F(1,52) = 3.82, p =.05, ŋp2 = 0.06, showing that in the control group females spent significantly more time in the center compared to males (p < 0.01), while in the BPA-exposed group no sex difference was found. It is worth noting that females of the control group spent slightly more time in the center compared to females exposed to BPA (p = 0.06). A statistically significant main effect of treatment was found for total amount of risk assessment, F(1,52) = 4.44, p = 0.04, ŋp2 = 0.08, showing that BPA treated animals performed less risk assessment compared to controls (Figure 1).
In relation to exploratory behavior, independently of BPA exposure, females spent more time performing head dipping compared to males, F(1,52) = 7.49, p <.01, ŋp2 = 0.12. The extent of this sex difference depended on BPA exposure, F(1,52) = 5.31, p =.02, ŋp2 = 0.09. Specifically, while in the control group, females performed more head-dips compared to males (p < 0.001); no differences were found in the BPA-exposed groups. Moreover, the effect of BPA was such that males and females exposed to BPA performed significantly less head dipping compared to control females (p < 0.01 and p < 0.05 respectively) (Figure 1).
2.4. Effects of Prenatal Exposure to BPA on Reproductive Behaviors of Males
There were no statistically significant differences between BPA treated and control males in terms of latency to mount, t(18) = –0.87, p = 0.40 or latency to first intromission t(18) = −0.30, p = 0.76. These results indicate that prenatal exposure to this low dose of BPA did not cause long term effects in male reproductive behaviors.
2.5. Effects of Prenatal Exposure to BPA on Receptor Density and Affinity in the Locus Coeruleus
A two-way ANOVA showed no effects of treatment, sex nor interaction between treatment and sex on receptor density. Overall, BPA-exposed mice showed a lower affinity (Kd) compared to controls, F(1,28) =10.23, p < 0.01, ŋp2 = 0.26. An exploratory analysis performed using sex-stratified data showed that while males from the control group and BPA were not different from each other, control females had higher affinity compared to BPA-exposed females, t(14) = 2.53, p = 0.02 (Figure 3c).
2.6. Effects of Prenatal Exposure to BPA on Receptor Density and Affinity in the Medial Preoptic Area
Overall females had a slightly higher receptor density compared to males, independently of BPA exposure, F(1,27) = 3.87, p =.05, ŋp2 = 0.12 (Figure 3a). However, there were no statistically significant effects of treatment or of the interaction between treatment and sex. It is worth noting that our preliminary analyses showed that planned comparisons suggest that in the control group females had larger density of receptors compared to males (d = 1.08, Table 1) but such difference did not survive the cut off of p < 0.025 required by the planned comparison. As for the LC, BPA-exposed mice showed a lower affinity compared to controls, F (1,27) = 7.82, p < 0.01, ŋp2 = 0.22 (Figure 3d), but no main effect of sex or statistically significant interaction was found. However, a follow up exploratory analysis using sex-stratified data showed that females exposed to BPA had a significantly lower affinity compared to females from the control group, t(13) = 2.45, p = 0.03, while this was not found in the male group (Figure 3d).
3. Discussion
An important and new finding of the present work is that the affinity and density of alpha2-adrenergic receptors in the adult brain can be altered by prenatal exposure to BPA, implying the possibility that these receptors’ pharmacodynamics and expression can be organized by sex steroids early during development and that BPA may interfere with this developmental process. Although our analysis of sex differences on alpha2 adrenergic receptors pharmacodynamics does not allow us to make strong inferences, we found an effect of BPA on receptor affinity in female mice such that they had lower affinity compared to females of the control group. Moreover, prenatal exposure to BPA reduced receptor affinity in both males and females compared to controls. We could not find sex differences in terms of receptor density, although our preliminary analysis suggests that in the preoptic area of the control group, males might have lower density compared to females. The catecholaminergic system is very sensitive to the organizational and activational effects of gonadal hormones. Sex differences in the sizes and volumes of key brain regions for catecholaminergic functioning, such as the LC, the midbrain and the hypothalamus, and in the expression of TH and dopamine beta hydroxylase (DBH), have been reported in young and adult rodents [16,21,50,51,52,53]. Specifically for alpha2 adrenergic receptors, it is known that in the adult of rodent species, sex steroids can have both sex and region-specific effects on the binding characteristics [54] and on receptor density in the hypothalamus of the adult female [55].
This is not the first study showing the long term, organizational effects of a biological or social event early during development on alpha2 adrenergic receptors. Several studies showed that the affinity of alpha2 adrenergic receptors in several brain areas, such as the nucleus of the tractus solitarius and the hypothalamus, was changed by early postnatal exposure to oxytocin in male rats exposed to maternal caloric restriction [56] and that pups exposed to poor maternal care showed lower density of alpha2 adrenergic receptors in the LC, an effect that was associated with higher fearfulness [57]. However, how these long term effects are produced is not well understood. Several possibilities could be envisioned, although these are based on observations carried out in the adult animal. One requires a change in the conformation of the receptor, for example, through phosphorylation, an effect possibly mediated by estrogen [58]. Another possibility, however, is that, following early exposure to BPA, in the LC and mPOA a change in the expression of different populations of alpha2 adrenergic receptors occurs that would consequently influence the measured binding affinity. However, the antagonist [3H]RX821002 has similar affinity for the four alpha2 adrenergic receptors [59], suggesting that this may not be the case. Other mechanisms would require regulatory effects on alpha2 adrenergic gene expression, possibly mediated by estrogen receptors. At present, we cannot explain the mechanisms leading to the effects of BPA on affinity changes and further studies are required.
Activation of alpha2 adrenergic receptor in several areas of the hypothalamus is required for the expression of endocrine and proceptive behaviors in the female rodent [36,60,61,62,63] and regulates sex behaviors in males [28,29]. The reduced affinity reported in the mPOA of prenatally BPA-exposed mice points to a possible overall catecholaminergic overstimulation that may have important effects on the female’s estrous cycle, reproductive behavior, body thermoregulation and sleep-wake cycle [64]. Remarkably, prenatal exposure to a low, yet relevant dose of BPA did not alter adult male sexual behavior, a finding that disagrees with what has been previously reported in rats [42,43]. However, our null results are in line with Picot and colleagues [65] who reported that in male mice developmental exposure to BPA at TDI or NOAEL dose did not affect sexual behavior or alter their neuroanatomical organization of the preoptic area. However, it is interesting to point out that, in female rodents, studies on the effects of developmental BPA exposure on sexual behavior reported contrasting outcomes, depending on the specie/strain, method and length of exposure to the chemical [66,67]. Here we conducted tests on sexual behavior only on male mice, as female mice do not display complex patterns of sexual behaviors compared to male mice or to female rats [68,69,70]. It is possible, however, that female proceptive behaviors could be affected by BPA exposure and further studies might assess this possibility.
Acute activation of alpha2-adrenergic receptors in the adult animal has been associated with vasodepressor and anti-stress effects in the CNS, for which the alpha2 adrenergic receptors in the LC play a prominent role [45,71]. Early exposure to stress alters the number and affinity of alpha2 adrenergic receptors in the LC of adult animals [56,57]. Similarly to what we have observed in the mPOA, prenatal exposure to BPA decreased receptor affinity in the LC, suggesting that BPA-exposed mice, independently of sex, could be characterized by an elevated noradrenergic output that, behaviorally, should correlate with higher locomotor activity, more arousal and anxious-like behaviors, in a similar way to what occurs in chronically stressed adult mice. When tested on the EPM, BPA-exposed mice were less anxious (lower levels of risk assessment) than controls. In line with expectations, in the EPM, BPA-exposed male mice did not differ from BPA females, at odds with the behavioral sex differences observed in controls (male controls spent more time on the closed arms and less time in the center and explored by means of fewer head dips than females). Overall present results on emotional response to a novel environment in BPA mice are in line with the historical literature from our laboratory [9,26,27]. When adult mice were challenged in the FOF, we observed that BPA-exposed males spent less time exploring the novel compartment but performed more vertical exploration than BPA females, whereas no sex differences were observed in controls. Compared to previous studies (9,27,28), BPA effects on behavioral responses in the FOF and in the EPM were less pronounced here, probably due to the fact that maternal exposure was restricted at the last week of gestation and did not include the first postnatal period. We have indeed reported that a single, very low dose of BPA exposure induced behavioral changes in anxiety and exploration measures, particularly in response to postnatal exposure [27].
In a previous study [44], we reported that prenatal exposure to a single, very low dose of BPA in mice results in changes in the psychopharmacological profile of only one sex. Male mice showed no behavioral alterations due to the BPA prenatal exposure in an amphetamine-induced conditioning paradigm, whereas BPA-exposed females showed a disruption in the amphetamine-induced conditioning. These and the present results substantiate the idea that the developing catecholaminergic system is vulnerable to the disruptive effects of BPA during sensitive periods of development. They also underscore the possibility that females are more vulnerable to BPA exposure during critical periods of development, suggesting sex-specific alterations in the function of brain neurochemical systems involved in reward and arousal. It is important to emphasize that in the present work we did not use a multidose-response paradigm; instead we used an established, single low dose of BPA that has been showed to have important developmental effects on neurobiological and behavioral endpoints [26,27,41,44]. As a general consideration, our results confirm a consistent finding in current Endocrine Disrupting Chemicals (EDCs) research: exposure to low doses of BPA in utero may disrupt the development of sex-specific behaviors by altering normal steroid programming of the brain, and this disruption affects males and females differently [72]. This implies the relevance of including an analysis of both sexes and of sexually differentiated/dimorphic responses when assessing the effects of developmental exposure to EDCs.
4. Materials and Methods
Experiments were conducted in accordance with the European Communities
Council Directive of 24 November 1986 (86/EEC) and approved by the Italian Institute of Health.
4.1. Maternal Treatment
Adult female CD-1 mice (Mus musculus domesticus) born and reared in our lab but originally purchased from Charles River Italia (Calco, Lecco, Italy) were time mated and group housed with food (4RF21 Mucedola, Milano, Italy) and water ad libitum. New Polycarbonate cages and bottles were used in order to minimize exogenous sources of endocrine disruption, as it was reported that BPA leaching at environmental temperatures is minimal under such conditions [73]. Beginning on day 6 after detection of the vaginal plug, females were trained to spontaneously drink a small volume (0.05 mL) of corn oil from a modified syringe (without the needle and with a larger hole) introduced through the cage top every day after 6 h the light onset. This procedure allows for accurate chemical administration without the stress associated with gavage or injection [41]. Starting from gestation day (GD) 11, each female was housed alone in a cage (30 × 14 × 13 cm) and randomly assigned one of the following treatments (10–12 females/group): corn oil alone for the control group, 10 μg/kg body weight/day (bw/d) of BPA. From GD 11–18, each female drank 0.1 mL of corn oil per 50 g bw/d, with or without the chemicals.
4.2. Birth and Weaning
Within 12 h following parturition (postnatal day—PND1), each litter was culled to 10 pups (5 ± 1 males and 5 ± 1 females), which were returned to their biological mothers. The pups were weighted at PND 1, 3, 10,15, 20 and 40. On PND 25, offspring were weaned and mice were group-housed with same-sex littermates in propylene cages (41 × 24 × 14 cm3) till the moment they were used for testing. To avoid the animals receiving olfactory stimulus from the other sex, males and females were stabled in different rooms until the day of sacrifice. At adulthood (60 days old), one male and one female per litter underwent the EPM, FOF or a sexual behavior test. Behavioral tests were conducted between 15:00 and 17:00 in a testing room, where experimental mice were brought 3 h prior testing in order to habituate to the new conditions. One male and one female per litter were left undisturbed and used for brain analysis. The animals were maintained and tested under a normal 12 h light: 12 h dark cycle.
4.3. Free-Exploratory Open Field Test (FOF)
We used a FOF apparatus as described in detail in Palanza and coworkers [74]. Briefly, the apparatus consisted of two sections: a home-cage and an unfamiliar OF. In the OF, a lamp posed near the apparatus wall produced a bright zone and a dark one. A camera posed above apparatus videotaped the whole test. At the end of each observation, floor and walls were accurately cleaned up with water, alcohol and then water again. The day before testing, mice (n = 14) were individually housed in the home-cage section. The testing day, the home-cage section was put in the apparatus and the connecting door was opened allowing mouse entrance in OF. A cut-off of 10 min was used for those animals that did not enter the OF. These animals were included in the statistical analysis with a latency to enter the OF of 600 and 0 s spent in the OF, while being excluded from further behavioral analysis. After the first entry (with the four paws) into the OF, mice were given 5 min maximum time to explore the novel environment. Latency to enter the OF (the time from opening of the home cage to actual mouse entrance into the OF with all four paws), risk assessment (forward elongation of the head and shoulders occurring from the home cage while scanning the unfamiliar OF), walking, rearing (standing with the forepaws up) and time in the OF were scored by means of the specific software The Observer (Noldus, Wageningen, The Netherland) by a trained observer who was blind about exposure categories of the experimental subjects. In addition, by means of the Ethovision program (Noldus) latency, frequency and time spent in several OF zones (light, dark, corners, center, outer-ring, near the home cage, far from the home-cage) were determined along with distance traveled (cm), and speed of movement (velocity, cm/s).
4.4. Elevated Plus Maze
The day after the FOF test, one male and one female from each litter were tested on the EPM. Briefly, a mouse was removed from the home-cage and placed in the center of the apparatus for a 5 min test. A camera posed above apparatus videotaped the whole test. At the end of each observation, floor and walls were accurately cleaned up with water, alcohol and then water again. Conventional behaviors were scored by means of The Observer (Noldus). These comprised the frequencies of open and closed-arm entries (arm entry defined as all four paws into an arm) and total arm entries; and the amounts of time spent by the animals in open, central and closed parts of the maze. These data were used to additionally calculate percent open entries (open/total × 100) and percent time spent in different maze sections (location/300 × 100). In addition, frequency and duration of stretched attend postures (SAP; exploratory posture in which the mouse stretches its body forward without moving one or both hind paws), flat-back approach behavior (exploratory behavior where the mouse stretches to its full length while slowly moving forward) and risk assessment (stretched attend postures performed scanning the open arms with one or both hind paws still in the closed arm or central area) were measured and analyzed as total risk assessment behavior.
4.5. Sociosexual Behavior
When 90 days old, a sexual behavior test was performed. Experimental males were exposed to an unfamiliar (age and strain matched) female in estrous or proestrous state, while experimental females in estrus or proestrus states were exposed to unfamiliar (age and strain matched) males. Estrous stage was determined through vaginal smears and microscopic identification, according to [63]. Tests were conducted in a novel and unfamiliar transparent cage (27 × 20 × 13cm) with no bedding to allow for observation by the transparent cage floor. Two cameras were placed immediately above and below the cage, to allow videotape recording and the identification of all stages of socio-sexual behavior. Socio-sexual interaction was videotaped for a 30 min period and behavioral data were collected according to Dadomo and colleagues [75]. Data analysis was based on the following behavioral categories: (1) Exploration: sniffing the cage, sniffing with the nose up in the air, rearing, attention posture and digging. (2) Grooming, divided into self-grooming: wiping, licking, nibbling its own fur and scratching movements; and allo-grooming: when all those behaviors were directed to a female. (3) Affiliation: sniffing the female’s body, sniffing the female’s muzzle. (4) Sexual: anogenital sniffing, mounts and attempts to mount, genital self-grooming, intromission and ejaculation. For each behavior reported above, the latency to, the total duration and the number of times were also recorded. Tapes were analyzed and scored by a trained observer using specific software (The Observer, Noldus). Each male and female participated in the experiment only once.
4.6. Receptor Autoradiography and Quantification
When 60 days old, 16 males and 16 females (8 males and females from each group) were sacrificed. The brains were quickly removed and frozen in liquid nitrogen. Cryostat sections (10 µm) were cut at −18 °C, thaw-mounted onto gelatin-coated glass slides and placed under vacuum at 4 °C overnight. Saturation experiments were performed with 9 different concentrations of the antagonist [3H] RX821002 ((1,4-[6,7(n)3H]-benzodioxan-2-methoxy-2-yl)-2-imidazole hydrochloride; specific activity 60.0 Ci/mmol; Amersham). Sections were incubated with [3H]RX821002 in buffer (50 mM K2HPO4/KH2PO4, ph 7,4; 5 mM MgCl2, 10 microM pargyline) for 60 min at 37 °C; washed in buffer twice for 2 min on ice, in distilled water (30s on ice); and dried under a stream of cold air. Non-specific binding was determined in the presence of a 1000-fold excess of yohimbine. Quantification of [3H]RX821002 binding sites was performed by autoradiography. Brain sections were exposed along with 20 µm 3H-microscale standards on tritium-sensitive Hyperfilm-3H (Amersham, Braunschweig, Germany) for 10 weeks at a temperature of 8–10 °C.
When 60 days old, 16 males and 16 females (8 males and females from each group) were sacrificed. The brains were quickly removed and frozen in liquid nitrogen. Cryostat sections (10 µm) were cut at −18 °C, thaw-mounted onto gelatin-coated glass slides and placed under vacuum at 4 °C overnight. Saturation experiments were performed with 9 different concentrations of the antagonist [3H] RX821002 ((1,4-[6,7(n)3H]-benzodioxan-2-methoxy-2-yl)-2-imidazole hydrochloride; specific activity 60.0 Ci/mmol; Amersham). Sections were incubated with [3H]RX821002 in buffer (50 mM K2HPO4/KH2PO4, ph 7,4; 5 mM MgCl2, 10 microM pargyline) for 60 min at 37 °C; washed in buffer twice for 2 min on ice, in distilled water (30s on ice); and dried under a stream of cold air. Non-specific binding was determined in the presence of a 1000-fold excess of yohimbine. Quantification of [3H]RX821002 binding sites was performed by autoradiography. Brain sections were exposed along with 20 µm 3H-microscale standards on tritium-sensitive Hyperfilm-3H (Amersham, Braunschweig, Germany) for 10 weeks at a temperature of 8–10 °C.
The films were analyzed densitometrically with a computerized image analysis system (MCID AIS, Imaging Research Inc., St Catherines, ON, Canada). Gray values of the standards were used to determine the amount of radioactivity bound to tissue sections, which was expressed in phentomoles bound per milligram (fmol/mg) tissue equivalents. The regions analyzed (Figure 4) was anatomically localized with a mouse brain atlas [76]. Data from saturation and competition experiments were generated with a curve fitting program: Graph Pad Prism (Graph Pad Software Inc., San Diego, CA, USA).
4.7. Statistical Analysis
For each dependent variable we present means and standard deviation for each sex across treatment in Table 1. Preliminary statistical analyses to explore sex differences across treatments (independent of treatment effect) were carried out by means of planned comparisons with Bonferroni’s adjustment (αPC = 0.025). Cohen’ d effect size and its relative 95% CI are also presented. The possibility that BPA exposure could affect sex differences was investigated by means of 2 × 2 factorial ANOVA and Tukey’s HSD was used for post-hoc multiple comparisons. Following Rich-Edwards et al. [77], in case of a statistically non-significant interaction, differential main effects of treatment were investigated by sex stratifying the data. Specifically, we investigated the possible effects of prenatal exposure to BPA separately for each sex by means of independent t-tests. All statistical analyses were performed using the SPSS 26 (IBM statistics, Armonk, NY, USA).
Author Contributions
Conceptualization, P.P., S.P. and L.G.; methodology, P.P., D.P. and L.G.; formal analysis, D.P.; investigation, D.P. and L.G.; resources, P.P; data curation, D.P.; writing—original draft preparation, D.P.; writing—review and editing, D.P., P.P, L.G. and S.P.; All authors have read and agreed to the published version of the manuscript.
Funding
This research was funded by the University of Parma and the Italian Ministry of University and Research (MIUR), grant number MM05107834_003.
Conflicts of Interest
The authors declare no conflict of interest.
References
- 1.Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA) Reprod. Toxicol. 2007;24:139–177. doi: 10.1016/j.reprotox.2007.07.010. [DOI] [PubMed] [Google Scholar]
- 2.Schönfelder G., Wittfoht W., Hopp H., Talsness C.E., Paul M., Chahoud I. Parent bisphenol a accumulation in the human maternal-fetal-placental unit. Environ. Health Perspect. 2002;110 doi: 10.1289/ehp.110-1241091. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3.Ikezuki Y., Tsutsumi O., Takai Y., Kamei Y., Taketani Y. Determination of bisphenol A concentrations in human biological fluids reveals significant early prenatal exposure. Hum. Reprod. 2002;17:2839–2841. doi: 10.1093/humrep/17.11.2839. [DOI] [PubMed] [Google Scholar]
- 4.Sun Y., Irie M., Kishikawa N., Wada M., Kuroda N., Nakashima K. Determination of bisphenol A in human breast milk by HPLC with column-switching and fluorescence detection. Biomed. Chromatogr. 2004;18:501–507. doi: 10.1002/bmc.345. [DOI] [PubMed] [Google Scholar]
- 5.vom Saal F.S., Welshons W.V. Evidence that bisphenol A (BPA) can be accurately measured without contamination in human serum and urine, and that BPA causes numerous hazards from multiple routes of exposure. Mol. Cell. Endocrinol. 2014;398:101–113. doi: 10.1016/j.mce.2014.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Welshons W.V., Nagel S.C., vom Saal F.S. Large Effects from Small Exposures. III. Endocrine Mechanisms Mediating Effects of Bisphenol A at Levels of Human Exposure. Endocrinology. 2006;147:s56–s69. doi: 10.1210/en.2005-1159. [DOI] [PubMed] [Google Scholar]
- 7.Zoeller R.T., Bansal R., Parris C. Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC3/neurogranin expression in the developing rat brain. Endocrinology. 2005;146:607–612. doi: 10.1210/en.2004-1018. [DOI] [PubMed] [Google Scholar]
- 8.Howdeshell K.L., Hotchkiss A.K., Thayer K.A., Vandenbergh J.G., Vom Saal F.S. Environmental toxins: Exposure to bisphenol A advances puberty. Nature. 1999;401:763–764. doi: 10.1038/44517. [DOI] [PubMed] [Google Scholar]
- 9.Palanza P., Gioiosa L., vom Saal F.S., Parmigiani S. Effects of developmental exposure to bisphenol A on brain and behavior in mice. Environ. Res. 2008;108:150–157. doi: 10.1016/j.envres.2008.07.023. [DOI] [PubMed] [Google Scholar]
- 10.Vandenberg L.N., Hunt P.A., Gore A.C. Endocrine disruptors and the future of toxicology testing—Lessons from CLARITY–BPA. Nat. Rev. Endocrinol. 2019;15:366–374. doi: 10.1038/s41574-019-0173-y. [DOI] [PubMed] [Google Scholar]
- 11.McCarthy M.M., Arnold A.P. Reframing sexual differentiation of the brain. Nat. Neurosci. 2011;14:677–683. doi: 10.1038/nn.2834. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Matsumoto A. Synaptogenic action of sex steroids in developing and adult neuroendocrine brain. Psychoneuroendocrinology. 1991;16:25–40. doi: 10.1016/0306-4530(91)90069-6. [DOI] [PubMed] [Google Scholar]
- 13.Arnold A.P., Gorski R.A. Gonadal Steroid Induction of Structural Sex Differences in the Central Nervous System. Annu. Rev. Neurosci. 1984;7:413–442. doi: 10.1146/annurev.ne.07.030184.002213. [DOI] [PubMed] [Google Scholar]
- 14.Simerly R.B. Wired for Reproduction: Organization and Development of Sexually Dimorphic Circuits in the Mammalian Forebrain. Annu. Rev. Neurosci. 2002;25:507–536. doi: 10.1146/annurev.neuro.25.112701.142745. [DOI] [PubMed] [Google Scholar]
- 15.Zhang J.M., Konkle A.T.M., Zup S.L., McCarthy M.M. Impact of sex and hormones on new cells in the developing rat hippocampus: A novel source of sex dimorphism? Eur. J. Neurosci. 2008;27:791–800. doi: 10.1111/j.1460-9568.2008.06073.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Guillamón A., de Blas M.R., Segovia S. Effects of sex steroids on the development of the locus coeruleus in the rat. Dev. Brain Res. 1988;40:306–310. doi: 10.1016/0165-3806(88)90143-5. [DOI] [PubMed] [Google Scholar]
- 17.Cooke B.M., Tabibnia G., Breedlove S.M. A brain sexual dimorphism controlled by adult circulating androgens. Proc. Natl. Acad. Sci. USA. 1999;96:7538–7540. doi: 10.1073/pnas.96.13.7538. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Berridge C.W., Waterhouse B.D. The locus coeruleus-noradrenergic system: Modulation of behavioral state and state-dependent cognitive processes. Brain Res. Rev. 2003;42:33–84. doi: 10.1016/S0165-0173(03)00143-7. [DOI] [PubMed] [Google Scholar]
- 19.Charmandari E., Tsigos C., Chrousos G. Endocrinology of the Stress Response. Annu. Rev. Physiol. 2005;67:259–284. doi: 10.1146/annurev.physiol.67.040403.120816. [DOI] [PubMed] [Google Scholar]
- 20.Sara S.J. The locus coeruleus and noradrenergic modulation of cognition. Nat. Rev. Neurosci. 2009;10:211–223. doi: 10.1038/nrn2573. [DOI] [PubMed] [Google Scholar]
- 21.Pinos H., Collado P., Rodríguez-Zafra M., Rodríguez C., Segovia S., Guillamón A. The development of sex differences in the locus coeruleus of the rat. Brain Res. Bull. 2001;56:73–78. doi: 10.1016/S0361-9230(01)00540-8. [DOI] [PubMed] [Google Scholar]
- 22.Pendergast J.S., Tuesta L.M., Bethea J.R. Oestrogen receptor β contributes to the transient sex difference in tyrosine hydroxylase expression in the mouse locus coeruleus. J. Neuroendocrinol. 2008;20:1155–1164. doi: 10.1111/j.1365-2826.2008.01776.x. [DOI] [PubMed] [Google Scholar]
- 23.Kubo K., Arai O., Ogata R., Omura M., Hori T., Aou S. Exposure to bisphenol A during the fetal and suckling periods disrupts sexual differentiation of the locus coeruleus and of behavior in the rat. Neurosci. Lett. 2001;304:73–76. doi: 10.1016/S0304-3940(01)01760-8. [DOI] [PubMed] [Google Scholar]
- 24.Kubo K., Arai O., Omura M., Watanabe R., Ogata R., Aou S. Low dose effects of bisphenol A on sexual differentiation of the brain and behavior in rats. Neurosci. Res. 2003;45:345–356. doi: 10.1016/S0168-0102(02)00251-1. [DOI] [PubMed] [Google Scholar]
- 25.Tando S., Itoh K., Yaoi T., Ogi H., Goto S., Mori M., Fushiki S. Bisphenol A exposure disrupts the development of the locus coeruleus-noradrenergic system in mice. Neuropathology. 2014;34:527–534. doi: 10.1111/neup.12137. [DOI] [PubMed] [Google Scholar]
- 26.Gioiosa L., Fissore E., Ghirardelli G., Parmigiani S., Palanza P. Developmental exposure to low-dose estrogenic endocrine disruptors alters sex differences in exploration and emotional responses in mice. Horm. Behav. 2007;52:307–316. doi: 10.1016/j.yhbeh.2007.05.006. [DOI] [PubMed] [Google Scholar]
- 27.Gioiosa L., Parmigiani S., vom Saal F.S., Palanza P. The effects of bisphenol A on emotional behavior depend upon the timing of exposure, age and gender in mice. Horm. Behav. 2013;63:598–605. doi: 10.1016/j.yhbeh.2013.02.016. [DOI] [PubMed] [Google Scholar]
- 28.Panzica G.C., Viglietti-Panzica C., Balthazart J. The sexually dimorphic medial preoptic nucleus of quail: A key brain area mediating steroid action on male sexual behavior. Front. Neuroendocrinol. 1996;17:51–125. doi: 10.1006/frne.1996.0002. [DOI] [PubMed] [Google Scholar]
- 29.Pfaff D.W., Baum M.J. Hormone-dependent medial preoptic/lumbar spinal cord/autonomic coordination supporting male sexual behaviors. Mol. Cell. Endocrinol. 2018;467:21–30. doi: 10.1016/j.mce.2017.10.018. [DOI] [PubMed] [Google Scholar]
- 30.Dobolyi A., Grattan D.R., Stolzenberg D.S. Preoptic inputs and mechanisms that regulate maternal responsiveness. J. Neuroendocrinol. 2014;26:627–640. doi: 10.1111/jne.12185. [DOI] [PubMed] [Google Scholar]
- 31.Gorski R.A., Gordon J.H., Shryne J.E., Southam A.M. Evidence for a morphological sex difference within the medial preoptic area of the rat brain. Brain Res. 1978;148:333–346. doi: 10.1016/0006-8993(78)90723-0. [DOI] [PubMed] [Google Scholar]
- 32.Bleier R., Byne W., Siggelkow I. Cytoarchitectonic sexual dimorphisms of the medial preoptic and anterior hypothalamic areas in guinea pig, rat, hamster, and mouse. J. Comp. Neurol. 1982;212:118–130. doi: 10.1002/cne.902120203. [DOI] [PubMed] [Google Scholar]
- 33.Tillet Y., Batailler M., Thibault J. Neuronal projections to the medial preoptic area of the sheep, with special reference to monoaminergic afferents: Immunohistochemical and retrograde tract tracing studies. J. Comp. Neurol. 1993;330:195–220. doi: 10.1002/cne.903300205. [DOI] [PubMed] [Google Scholar]
- 34.Simerly R.B., Zee M.C., Pendleton J.W., Lubahn D.B., Korach K.S. Estrogen receptor-dependent sexual differentiation of dopaminergic neurons in the preoptic region of the mouse. Proc. Natl. Acad. Sci. USA. 1997;94:14077–14082. doi: 10.1073/pnas.94.25.14077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Herbison A.E. Noradrenergic regulation of cyclic GnRH secretion. Rev. Reprod. 1997;2:1–6. doi: 10.1530/ror.0.0020001. [DOI] [PubMed] [Google Scholar]
- 36.Vathy I., Etgen A.M. Hormonal Activation of Female Sexual Behavior is Accompanied by Hypothalamic Norepinephrine Release. J. Neuroendocrinol. 1989;1:383–388. doi: 10.1111/j.1365-2826.1989.tb00133.x. [DOI] [PubMed] [Google Scholar]
- 37.Cornil C.A., Balthazart J., Motte P., Massotte L., Seutin V. Dopamine activates noradrenergic receptors in the preoptic area. J. Neurosci. 2002;22:9320–9330. doi: 10.1523/JNEUROSCI.22-21-09320.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Cornil C.A., Ball G.F. Interplay among catecholamine systems: Dopamine binds to α 2-adrenergic receptors in birds and mammals. J. Comp. Neurol. 2008;511:610–627. doi: 10.1002/cne.21861. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.He Z., Paule M.G., Ferguson S.A. Low oral doses of bisphenol A increase volume of the sexually dimorphic nucleus of the preoptic area in male, but not female, rats at postnatal day 21. Neurotoxicol. Teratol. 2012;34:331–337. doi: 10.1016/j.ntt.2012.03.004. [DOI] [PubMed] [Google Scholar]
- 40.Rubin B.S., Lenkowski J.R., Schaeberle C.M., Vandenberg L.N., Ronsheim P.M., Soto A.M. Evidence of altered brain sexual differentiation in mice exposed perinatally to low, environmentally relevant levels of bisphenol A. Endocrinology. 2006;147:3681–3691. doi: 10.1210/en.2006-0189. [DOI] [PubMed] [Google Scholar]
- 41.Palanza P., Howdeshell K.L., Parmigiani S., vom Saal F.S. Exposure to a low dose of bisphenol A during fetal life or in adulthood alters maternal behavior in mice. Environ. Health Perspect. 2002;110:415–422. doi: 10.1289/ehp.02110s3415. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42.Jones B.A., Shimell J.J., Watson N.V. Pre- and postnatal bisphenol A treatment results in persistent deficits in the sexual behavior of male rats, but not female rats, in adulthood. Horm. Behav. 2011;59:246–251. doi: 10.1016/j.yhbeh.2010.12.006. [DOI] [PubMed] [Google Scholar]
- 43.Farabollini F., Porrini S., Della Seta D., Bianchi F., Dessì-Fulgheri F. Effects of perinatal exposure to bisphenol A on sociosexual behavior of female and male rats. Environ. Health Perspect. 2002;110:409–414. doi: 10.1289/ehp.02110s3409. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Laviola G., Gioiosa L., Adriani W., Palanza P. D-Amphetamine-related reinforcing effects are reduced in mice exposed prenatally to estrogenic endocrine disruptors. Brain Res. Bull. 2005;65:235–240. doi: 10.1016/j.brainresbull.2004.11.015. [DOI] [PubMed] [Google Scholar]
- 45.Flügge G. Alterations in the central nervous α2-adrenoceptor system under chronic psychosocial stress. Neuroscience. 1996;75:187–196. doi: 10.1016/0306-4522(96)00292-8. [DOI] [PubMed] [Google Scholar]
- 46.Starke K. Presynaptic autoreceptors in the third decade: Focus on α2-adrenoceptors. J. Neurochem. 2001;78:685–693. doi: 10.1046/j.1471-4159.2001.00484.x. [DOI] [PubMed] [Google Scholar]
- 47.Wang R., Macmillan L.B., Fremeau R.T., Magnuson M.A., Lindner J., Limbird L.E. Expression of α2-adrenergic receptor subtypes in the mouse brain: Evaluation of spatial and temporal information imparted by 3 kb of 5′ regulatory sequence for the α2A AR-receptor gene in transgenic animals. Neuroscience. 1996;74:199–218. doi: 10.1016/0306-4522(96)00116-9. [DOI] [PubMed] [Google Scholar]
- 48.Scheinin M., Lomasney J.W., Hayden-Hixson D.M., Schambra U.B., Caron M.G., Lefkowitz R.J., Fremeau R.T. Distribution of α2-adrenergic receptor subtype gene expression in rat brain. Mol. Brain Res. 1994;21:133–149. doi: 10.1016/0169-328X(94)90386-7. [DOI] [PubMed] [Google Scholar]
- 49.Lakens D. Calculating and reporting effect sizes to facilitate cumulative science: A practical primer for t-tests and ANOVAs. Front. Psychol. 2013;4 doi: 10.3389/fpsyg.2013.00863. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Küppers E., Ivanova T., Karolczak M., Beyer C. Estrogen: A multifunctional messenger to nigrostriatal dopaminergic neurons. J. Neurocytol. 2000;29:375–385. doi: 10.1023/A:1007165307652. [DOI] [PubMed] [Google Scholar]
- 51.Ivanova T., Beyer C. Estrogen regulates tyrosine hydroxylase expression in the neonate mouse midbrain. J. Neurobiol. 2003;54:638–647. doi: 10.1002/neu.10193. [DOI] [PubMed] [Google Scholar]
- 52.Luque J.M., de Blas M.R., Segovia S., Guillamón A. Sexual dimorphism of the dopamine-β-hydroxylase-immunoreactive neurons in the rat locus ceruleus. Dev. Brain Res. 1992;67:211–215. doi: 10.1016/0165-3806(92)90221-H. [DOI] [PubMed] [Google Scholar]
- 53.Thanky N.R., Son J.H., Herbison A.E. Sex differences in the regulation of tyrosine hydroxylase gene transcription by estrogen in the locus coeruleus of TH9-LacZ transgenic mice. Brain Res. Mol. Brain Res. 2002;104:220–226. doi: 10.1016/S0169-328X(02)00383-2. [DOI] [PubMed] [Google Scholar]
- 54.Johnson A.E., Nock B., McEwen B.S., Feder H.H. A1- and A2-Noradrenergic Receptor Binding in Guinea Pig Brain: Sex Differences and Effects of Ovarian Steroids. Brain Res. 1988;442:205–213. doi: 10.1016/0006-8993(88)91505-3. [DOI] [PubMed] [Google Scholar]
- 55.Karkanias G.B., Etgen A.M. A thermodynamic analysis of estrogen regulation ofα2-adrenoceptor binding. Brain Res. 1995;674:26–32. doi: 10.1016/0006-8993(94)01425-H. [DOI] [PubMed] [Google Scholar]
- 56.Díaz-Cabiale Z., Olausson H., Sohlström A., Agnati L.F., Narváez J.A., Uvnäs-Moberg K., Fuxe K. Long-term modulation by postnatal oxytocin of the α 2-adrenoceptor agonist binding sites in central autonomic regions and the role of prenatal stress. J. Neuroendocrinol. 2004;16:183–190. doi: 10.1111/j.0953-8194.2004.01146.x. [DOI] [PubMed] [Google Scholar]
- 57.Caldji C., Tannenbaum B., Sharma S., Francis D., Plotsky P.M., Meaney M.J. Maternal care during infancy regulates the development of neural systems mediating the expression of fearfulness in the rat. Proc. Natl. Acad. Sci. USA. 1998;95:5335–5340. doi: 10.1073/pnas.95.9.5335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Ansonoff M.A., Etgen A.M. Receptor phosphorylation mediates estradiol reduction of α 2-adrenoceptor coupling to G protein in the hypothalamus of female rats. Endocrine. 2001;14:165–174. doi: 10.1385/ENDO:14:2:165. [DOI] [PubMed] [Google Scholar]
- 59.O’Rourke M.F., Blaxall H.S., Iversen L.J., Bylund D.B. Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J. Pharmacol. Exp. Ther. 1994;268:1362–1367. [PubMed] [Google Scholar]
- 60.Karkanias G.B., Etgen A.M. Estradiol attenuates α2-adrenoceptor-mediated inhibition of hypothalamic norepinephrine release. J. Neurosci. 1993;13:3448–3455. doi: 10.1523/JNEUROSCI.13-08-03448.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61.Etgen A.M., Karkanias G.B. Estrogen regulation of noradrenergic signaling in the hypothalamus. Psychoneuroendocrinology. 1994;19:603–610. doi: 10.1016/0306-4530(94)90044-2. [DOI] [PubMed] [Google Scholar]
- 62.Meston C.M., Moe I.V., Gorzalka B.B. Effects of sympathetic inhibition on receptive, proceptive, and rejection behaviors in the female rat. Physiol. Behav. 1996;59:537–542. doi: 10.1016/0031-9384(95)02102-7. [DOI] [PubMed] [Google Scholar]
- 63.Herbison A.E., Simonian S.X., Thanky N.R., Bicknell R.J. Oestrogen modulation of noradrenaline neurotransmission. Novartis Found. Symp. 2000;230:74–93. doi: 10.1002/0470870818.ch7. [DOI] [PubMed] [Google Scholar]
- 64.Kumar V.M., Vetrivelan R., Mallick H.N. Noradrenergic afferents and receptors in the medial preoptic area: Neuroanatomical and neurochemical links between the regulation of sleep and body temperature. Neurochem. Int. 2007;50:783–790. doi: 10.1016/j.neuint.2007.02.004. [DOI] [PubMed] [Google Scholar]
- 65.Picot M., Naulé L., Marie-Luce C., Martini M., Raskin K., Grange-Messent V., Franceschini I., Keller M., Mhaouty-Kodja S. Vulnerability of the neural circuitry underlying sexual behavior to chronic adult exposure to oral bisphenol A in male mice. Endocrinology. 2014;155:502–512. doi: 10.1210/en.2013-1639. [DOI] [PubMed] [Google Scholar]
- 66.Ferguson S.A., Law C.D. elber.; Kissling, G.E. Developmental treatment with ethinyl estradiol, but not bisphenol A, causes alterations in sexually dimorphic behaviors in male and female Sprague Dawley rats. Toxicol. Sci. 2014;140:374–392. doi: 10.1093/toxsci/kfu077. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 67.Naulé L., Picot M., Martini M., Parmentier C., Hardin-Pouzet H., Keller M., Franceschini I., Mhaouty-Kodja S. Neuroendocrine and behavioral effects of maternal exposure to oral bisphenol A in female mice. J. Endocrinol. 2014;220:375–388. doi: 10.1530/JOE-13-0607. [DOI] [PubMed] [Google Scholar]
- 68.Bonthuis P.J., Cox K.H., Searcy B.T., Kumar P., Tobet S., Rissman E.F. Of mice and rats: Key species variations in the sexual differentiation of brain and behavior. Front. Neuroendocrinol. 2010;31:341–358. doi: 10.1016/j.yfrne.2010.05.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 69.Beach F.A. Sexual attractivity, proceptivity, and receptivity in female mammals. Horm. Behav. 1976;7:105–138. doi: 10.1016/0018-506X(76)90008-8. [DOI] [PubMed] [Google Scholar]
- 70.McGill T.E. Sexual Behavior in Three Inbred Strains of Mice. Behaviour. 2008;19:341–350. doi: 10.1163/156853962X00087. [DOI] [Google Scholar]
- 71.Flügge G., Ahrens O., Fuchs E. Monoamine receptors in the prefrontal cortex of Tupaia belangeri during chronic psychosocial stress. Cell Tissue Res. 1997;288:1–10. doi: 10.1007/s004410050787. [DOI] [PubMed] [Google Scholar]
- 72.Palanza P., Nagel S.C., Parmigiani S., vom Saal F.S. Perinatal exposure to endocrine disruptors: Sex, timing and behavioral endpoints. Curr. Opin. Behav. Sci. 2016;7:69–75. doi: 10.1016/j.cobeha.2015.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 73.Howdeshell K.L., Peterman P.H., Judy B.M., Taylor J.A., Orazio C.E., Ruhlen R.L., vom Saal F.S., Welshons W.V. Bisphenol A is released from used polycarbonate animal cages into water at room temperature. Environ. Health Perspect. 2003;111:1180–1187. doi: 10.1289/ehp.5993. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 74.Palanza P., Gioiosa L., Parmigiani S. Social stress in mice: Gender differences and effects of estrous cycle and social dominance. Physiol. Behav. 2001;73:411–420. doi: 10.1016/S0031-9384(01)00494-2. [DOI] [PubMed] [Google Scholar]
- 75.Dadomo H., Volpi R., Ferrari M., Vignali A., Bartolomucci A., Palanza P., Parmigiani S. Sildenafil counteracts the inhibitory effect of social subordination on competitive aggression and sexual motivation in male mice. Behav. Brain Res. 2011;216:193–199. doi: 10.1016/j.bbr.2010.07.036. [DOI] [PubMed] [Google Scholar]
- 76.Paxinos G., Franklin K.B.J. The MouseBrain in Stereotaxic Coordinates. 2nd ed. Academic Press; San Diego, CA, USA: 2001. [Google Scholar]
- 77.Rich-Edwards J.W., Kaiser U.B., Chen G.L., Manson J.A.E., Goldstein J.M. Sex and gender differences research design for basic, clinical, and population studies: Essentials for investigators. Endocr. Rev. 2018;39:424–439. doi: 10.1210/er.2017-00246. [DOI] [PMC free article] [PubMed] [Google Scholar]